PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 28.6 CHF -0.52% Market Closed
Market Cap: 943.3m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Net Margin
PolyPeptide Group AG

-8.7%
Current
-1%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-28.6m
/
Revenue
327.3m

Net Margin Across Competitors

Country CH
Market Cap 943.3m CHF
Net Margin
-9%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 202.3B USD
Net Margin
14%
Country US
Market Cap 166.6B USD
Net Margin
18%
Country KR
Market Cap 66.8T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
20%
Country US
Market Cap 36.3B USD
Net Margin
9%
Country US
Market Cap 27B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
17%
Country CN
Market Cap 164.6B CNY
Net Margin
21%
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
943.3m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
27.95 CHF
Overvaluation 2%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-28.6m
/
Revenue
327.3m
What is the Net Margin of PolyPeptide Group AG?

Based on PolyPeptide Group AG's most recent financial statements, the company has Net Margin of -8.7%.